The Scottish enhanced Staphylococcus aureus bacteraemia surveillance programme: the first 18 months of data in

F Murdoch1, J Danial2, A K Morris3

  • 1Health Protection Scotland, NHS National Services Scotland, Glasgow, UK.

Insights

National enhanced surveillance of Staphylococcus aureus bacteraemia (SAB) in children revealed distinct patterns. Hospital-acquired SAB primarily affected neonates with devices, while community-acquired SAB occurred in older children with few risk factors, often presenting with bone or joint infections.

Area of Science:

  • Pediatric Infectious Diseases
  • Epidemiology
  • Public Health Surveillance

Background:

  • National enhanced surveillance for Staphylococcus aureus bacteraemia (SAB) initiated in Scotland in October 2014.
  • Paediatric populations (under 16 years) were analyzed separately due to known epidemiological differences.

Purpose of the Study:

  • To identify key risk factors and high-risk patient groups for SAB in children.
  • To inform the development of targeted intervention strategies for SAB prevention and control.

Main Methods:

  • Mandatory enhanced surveillance involving all NHS Scotland boards.
  • Data collection by trained personnel using standardized definitions.

Main Results:

  • Analysis of 18 months of data revealed distinct patterns for hospital-acquired versus community-associated SAB.
  • Hospital-acquired SAB was predominantly linked to neonates with indwelling devices.
  • Community-associated SAB was more common in older children, often without identifiable risk factors, and frequently presented as bone or joint infections.

Conclusions:

  • Enhanced SAB surveillance data underscore significant differences in risk factors and acquisition pathways within the paediatric population.
  • Findings highlight the need for tailored approaches to managing SAB in different paediatric subgroups.
Abstract